Yadi Liao

State Key Laboratory Of Oncology In South China And Collaborative Innovation Center For Cancer Medicine
Guangzhou, 510030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Commentary on 'Liver resection versus transarterial chemoembolisation for the treatment of intermediate hepatocellular carcinoma: a systematic review and meta-analysis'.

Commentary on 'Liver resection versus transarterial chemoembolisation for the treatment of intermediate hepatocellular carcinoma: a systematic review and meta-analysis'.

Journal: International journal of surgery (London, England)

Published: September 02, 2023

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.

Journal: Nature communications

Published: May 31, 2022

S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.

S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 15, 2022

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 18, 2022

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 14, 2020

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study.

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study.

Journal: Annals of translational medicine

Published: September 21, 2020

Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.

Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.

Journal: Digestive surgery

Published: March 25, 2020

Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.

Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.

Journal: Journal of cancer research and clinical oncology

Published: March 05, 2020

Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma.

Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma.

Journal: Theranostics

Published: January 05, 2020

Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.

Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 10, 2019

Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.

Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.

Journal: European radiology

Published: December 05, 2018

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis.

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis.

Journal: Therapeutic advances in medical oncology

Published: November 28, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026